Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy.

Said DahbourFatima JamaliDana AlhattabAli Al-RadaidehOsama AbabnehNosaiba Al-RyalatMuawyeh Al-BdourBayan HouraniMohammed MsallamMurad RasheedAmmar HuneitiYacoub BahouEmad TarawnehAbdalla Awidi

Published in: CNS neuroscience & therapeutics (2017)

The used protocol was safe and feasible with possible efficacy. The addition of MSC-CM could be related to the magnitude of EDSS improvement observed.

Keyphrases

multiple sclerosis
mesenchymal stem cells
end stage renal disease
ejection fraction
newly diagnosed
randomized controlled trial
chronic kidney disease
prognostic factors
peritoneal dialysis
bone marrow
white matter
patient reported